SPRB Stock Forecast - 2022, 2025, 2030|GlobalFinancialTrends

SPRB Stock Forecast – 2022, 2023, 2024, 2025, 2030

26
SPRB Stock Forecast – 2022, 2023, 2024, 2025, 2030

SPRB Stock Forecast 2022, 2023, 2024, 2025, 2030

Spruce Biosciences Inc Shares (SPRB Stock) jumped 21% on Friday following Oppenheimer’s optimistic remark.

Hartaj Singh, an expert at Oppenheimer, launched coverage of Spruce Biosciences Inc Shares with an outperform outlook and a $15 SPRB Stock Price target, citing the Spruce Biosciences Inc as a strong biotech stock.

Spruce Biosciences Inc is a late-stage biopharmaceutical firm established in the United States that is focused on researching and commercializing medicines for uncommon endocrine diseases. Tildacerfont, Spruce Biosciences Inc’s primary pharmaceutical candidate, is a possible therapy for congenital adrenal hyperplasia, an uncommon endocrine disorder.

Singh warned investors in a report that the latest clinical delay “does not represent the excellence of this biotech enterprise.”

SPRB Stock Price Today

Currently, SPRB Stock Price is 5.03 USD, +2.55 (102.82%) today.

14 Days Historical SPRB Stock Price Data

Date Opening SPRB Stock Price Closing SPRB Stock Price Minimum SPRB Stock Price Maximum SPRB Stock Price
2021-12-17 Open: 2.79 Close: 5.03 Low: 2.79 High: 5.03
2021-12-16 Open: 2.5 Close: 2.48 Low: 2.48 High: 2.515
2021-12-15 Open: 2.4 Close: 2.5 Low: 2.4 High: 2.5
2021-12-14 Open: 2.37 Close: 2.43 Low: 2.35 High: 2.43
2021-12-13 Open: 2.3908 Close: 2.49 Low: 2.325 High: 2.49
2021-12-10 Open: 2.65 Close: 2.52 Low: 2.52 High: 2.825
2021-12-09 Open: 2.72 Close: 2.56 Low: 2.52 High: 2.725
2021-12-08 Open: 2.55 Close: 2.72 Low: 2.55 High: 2.7401
2021-12-07 Open: 2.557 Close: 2.55 Low: 2.48 High: 2.557
2021-12-06 Open: 2.34 Close: 2.4 Low: 2.34 High: 2.4
2021-12-03 Open: 2.3528 Close: 2.33 Low: 2.3216 High: 2.38
2021-12-02 Open: 2.46 Close: 2.47 Low: 2.45 High: 2.47
2021-12-01 Open: 2.58 Close: 2.41 Low: 2.4 High: 2.635
2021-11-30 Open: 2.605 Close: 2.58 Low: 2.51 High: 2.605

Historical SPRB Stock Price data:

  • Market Cap of Spruce Biosciences Inc Shares (Previous Close): 59.13 M
  • SPRB Stock Price in USD (Previous Close): 5.030
  • Spruce Biosciences Inc Shares Volume (Previous Close): 2.56 M
  • SPRB Stock Price in USD (Last): 5.030
  • 52 Week Change of Spruce Biosciences Inc Shares: -17.4089
  • 90-Day Moving Average of Spruce Biosciences Inc Shares: 4.328
  • 52 Week High SPRB Stock Price: 28.49
  • 52 Week Low SPRB Stock Price: 2.25
  • Spruce Biosciences Inc Shares’ 50 Day Moving Average: 3.9729
  • 200 Day Moving Average of Spruce Biosciences Inc Shares: 10.1195
  • Shares Short: 527736
  • Shares Short Prior Month: 476168
  • Short Ratio: 2.29
  • Short Percent: 0.0297

What Does Spruce Biosciences Inc Do?

What Does Spruce Biosciences Inc Do

Spruce Biosciences Inc is a biopharmaceutical firm specializing on the development and commercialization of new medicines for rare endocrine illnesses. Spruce Biosciences Inc is working on developing tildacerfont, a non-steroidal medication that will improve disease management and minimize steroid burden in patients with congenital adrenal hyperplasia (CAH). It provides tildacerfont, which is now in Phase II clinical trials for kids with classic CAH and women with polycystic ovarian syndrome.

Furthermore, it is involved in the development of CAHmelia-203, which is currently in Phase 2b clinical trials for elderly patients with classic CAH with poor disease management, and CAHmelia-204, which is currently in Phase 2b clinical trials for elderly patients with classic CAH with good disease management. Eli Lilly and Business has granted the company a license to investigate, develop, and commercialize compounds for diverse pharmaceutical applications. Spruce Biosciences Inc was founded in 2014 and is based in Daly City, California.

SPRB Stock News

SPRB Stock News

Spruce Biosciences Inc shares gained 22.6 percent in early trade after Oppenheimer expert Hartaj Singh began following the stock with an outperform rating and a price objective of $15.

The good rating elicited a positive reaction from shareholders, as indicated by the Spruce Biosciences Inc‘s share price increase during premarket trading hours. Nevertheless, the recovery to $3 is a far cry from the expert’s $15 objective.

Patients with Classic Congenital Adrenal Hyperplasia, CAHmelia-203 and CAHmelia-204, are being enrolled in a research trial of the biotech firm’s Tildercefont medication development.

The medicine is intended for both adults and children dealing with the aforementioned condition.

Spruce Biosciences Inc Share’s price has dropped 89.8 percent since January as traders have taken a wait-and-see approach to the firm.

Spruce Biosciences Inc’s most recent important statement was on November 15, 2021, when it revealed its Q3 financial results, which shocked with a loss of $0.49, topping analysts’ average projections of a $0.57 loss.

Investors searching for low-risk biotech options may explore the Spruce Biosciences Inc, but given its large losses, we would wait for a strong rally before investing.

Is SPRB Stock a Buy Right Now?

Spruce Biosciences Inc (SPRB Stock) is up 19.35 percent in pre-market trade to 2.96 on Friday. According to SPRB Stock Forecast news, SPRB Stock’s short-term technical rating shows that the SPRB Stock Price has moved less bullishly throughout the last month than 100% of the industry. SPRB Stock ranks higher than the stocks in the Biotechnology sector, which is 141 out of 146 sectors. SPRB Stock Price has down 19.48 percent in the last month, ending at $2.93 on November 19.

Throughout this phase, the SPRB Stock Price plummeted as low as $2.33 and as high as $2.99. SPRB Stock has an average rating of Buy, as per the SPRB Stock Forecast experts. Also, based on SPRB Stock Forecast 2022, 2023, 2024, 2025, 2030 data, the Spruce Biosciences Inc’s average SPRB Stock Price goal is $10.67.

SPRB Stock Forecast

SPRB Stock Forecast for the next days

Date SPRB Stock Price Min SPRB Stock Price Max SPRB Stock Price
2021-12-20 Price: 3.359 Min: 3.013 Max: 3.685
2021-12-21 Price: 3.362 Min: 3.027 Max: 3.675
2021-12-22 Price: 3.412 Min: 3.095 Max: 3.740
2021-12-23 Price: 3.460 Min: 3.141 Max: 3.786
2021-12-24 Price: 3.686 Min: 3.344 Max: 4.046
2021-12-27 Price: 3.325 Min: 3.004 Max: 3.678
2021-12-28 Price: 3.328 Min: 2.999 Max: 3.668
2021-12-29 Price: 3.378 Min: 3.055 Max: 3.744
2021-12-30 Price: 3.427 Min: 3.073 Max: 3.757
2021-12-31 Price: 3.652 Min: 3.318 Max: 3.992

 

SPRB Stock Forecast data:

  • 52 Week High SPRB Stock Forecast: 2.150
  • 52 Week Low SPRB Stock Forecast: 0.000001
  • 45-Day Moving Average of Future SPRB Stock Price: 0.825
  • 90-Day Moving Average of Future SPRB Stock Price: 0.4062
  • According to SPRB Stock Forecast data, the price of Spruce Biosciences Inc Shares may decline from 5.030 USD to 0.000001 USD. The change will be -100.00%.

 

Below you can find the SPRB Stock Forecast data for next year.

Date Opening SPRB Stock Price Closing SPRB Stock Price Minimum SPRB Stock Price Maximum SPRB Stock Price Change
SPRB Stock Forecast for 2022
January 2022 Open: 1.200 Close: 0.004075 Min: 0.004075 Max: 1.200 Change: -29354.48 %▼
February 2022 Open: 0.003056 Close: 0.000013 Min: 0.0000129 Max: 0.003056 Change: -23550.24 %▼
March 2022 Open: 0.000010 Close: 0.000001 Min: 0.000001 Max: 0.00000969 Change: -55960.03 %▼
April 2022 Open: 0.000001 Close: 0.000001 Min: 0.000001 Max: 0.000001 Change: -31433.63 %▼
May 2022 Open: 0.000001 Close: 0.000001 Min: 0.000001 Max: 0.000001 Change: -41944.93 %▼